Salmonella fears spur major recall of pet treats

February 21, 2013 in Diseases, Conditions, Syndromes

Salmonella fears spur major recall of pet treats

Brands such as Colorado Naturals, Nature's Deli are included.

(HealthDay)— Boots & Barkley, Colorado Naturals and Nature's Deli are among the many pet treat brands being recalled by an American company due to possible salmonella contamination, the U.S. Food and Drug Administration said Thursday.

Kasel Associates Industries Inc. is recalling all pet treats it manufactured between April 20 and Sept. 19, 2012. The company has issued three previous recall notices for specific products produced during this time period.

The action comes after the Colorado Department of Agriculture tested a sample of a Kasel pet treat product from a store and found it to be positive for . A follow-up FDA inspection at the company found that all of the finished pet treat product samples and 48 out of 87 environmental samples from the manufacturing facility tested positive for salmonella.

More than 10 different types of salmonella were found in the company's treats and the production plant, indicating multiple sources of contamination, the FDA said in an agency news release.

The pet treats made by Kasel are sold at various retailers, including Target, Petco, Sam's Club and Costco. Most of the products have a two-year shelf life.

There have not been any reports of human illness associated with the pet treats, but there have been complaints of illnesses in dogs who ate the treats, according to the agency.

Both people and animals can contract salmonella from handling or eating contaminated products. After handling dry pet treats, people should thoroughly wash their hands as well as any surfaces touched by the products, the FDA said.

Consumers who have the recalled products, or who are unsure of the manufacturing date of their pet treats, should dispose of them safely by placing them in a securely lidded garbage can.

The recall is not related to the FDA's ongoing investigation of jerky pet treats made in China.

Symptoms of salmonella infection in pets include lethargy, diarrhea or bloody diarrhea, fever, vomiting, decreased appetite and abdominal pain. Pets who have eaten the recalled treats and are experiencing any of these symptoms should be taken to a veterinarian, the FDA advised.

The agency also noted that infected, but otherwise healthy pets, can be carriers and infect other animals or people.

Symptoms of salmonella infection in people can include nausea, vomiting, diarrhea or bloody diarrhea, abdominal cramps and fever. People who develop these symptoms after handling the recalled pet treats should see their doctor, the FDA said.

More information: Here's where you can find a complete list of the recalled pet treats.

Health News Copyright © 2013 HealthDay. All rights reserved.

not rated yet  

Rank not rated yet
Tags

Related Stories
Relevant PhysicsForums posts

More news stories

Impossible to predict outcome in China's bird flu outbreak, WHO says

It is impossible to predict the evolution of China's human H7N9 bird flu outbreak as researchers are still trying to understand the source of human transmission, the head of the World Health Organisation said Monday.

Diseases, Conditions, Syndromes created 7 minutes ago | popularity not rated yet | comments 0

Computer model predicts when viruses become infectious

A new computer model could help scientists predict when a particular strain of avian influenza might become infectious from bird to human, according to a report to be published in the International Journal Data Mining an ...

Diseases, Conditions, Syndromes created 28 minutes ago | popularity not rated yet | comments 0

New study identifies risk factors for depression among COPD patients

Patients suffering from chronic obstructive pulmonary disease (COPD) typically suffer from depression more frequently than those without COPD, resulting in higher levels of disability and illness and increasing the overall ...

Diseases, Conditions, Syndromes created 2 hours ago | popularity not rated yet | comments 0

Pharmaceutical advances offer new options for health outcomes

Research presented at Digestive Disease Week (DDW) explores pharmaceutical advances for treating irritable bowel syndrome with diarrhea (IBS-D) and hepatitis C.

Diseases, Conditions, Syndromes created 2 hours ago | popularity not rated yet | comments 0

Metabolic biomarkers can predict mortality in the ICU

A metabolic profile of intensive care unit (ICU) patients based on biomarkers of four metabolites can be used to accurately predict mortality, according to a new study.

Diseases, Conditions, Syndromes created 2 hours ago | popularity not rated yet | comments 0


Atherosclerotic disease heredity mapped in nationwide study

Researchers at Lund University in Sweden have mapped the significance of heredity for common forms of atherosclerotic disease. No studies have previously examined whether different forms of the disease share heredity.

FDA has safety concerns on Merck insomnia drug

Federal health regulators say an experimental insomnia drug from Merck can help patients fall asleep, but it also carries worrisome side effects, including daytime drowsiness and suicidal thinking.

Women with severe injuries are less likely than men to be treated in a trauma center

Women are less likely than men to receive care in a trauma center after severe injury, according to a new study of almost 100,000 Canadian patients.

Neurons that can multitask greatly enhance the brain's computational power, study finds

Over the past few decades, neuroscientists have made much progress in mapping the brain by deciphering the functions of individual neurons that perform very specific tasks, such as recognizing the location ...

Anabolic steroids may affect future mental health

There is a link between use of anabolic-androgenic steroids and reduced mental health later in life. This is the main conclusion of a new study on elite male strength athletes that researchers from the University of Gothenburg ...

Team finds mechanism linking key inflammatory marker to cancer

In a new study described in the journal Oncogene, researchers reveal how a key player in cell growth, immunity and the inflammatory response can be transformed into a primary contributor to tumor growth.